Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cappelli

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Journal of Endocrinological Investigation|June 10, 2024
Changes in body composition in early breast cancer patients treated with aromatase inhibitorsR Pedersini, G Schivardi, L Laini, et al.
The Journal of Investigative Dermatology|May 23, 2022
Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance StudyThomas K Le, Isabelle Brown, Rebecca Goldberg, et al.
Journal of Translational Medicine|March 5, 2024
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockadeShuming Chen, Tracee L McMiller, Abha Soni, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse EventsJarushka Naidoo, Jiajia Zhang, Evan J Lipson, et al.
The Oncologist|July 27, 2024
Immune-related encephalitis after immune checkpoint inhibitor therapyMonica W Buckley, Aanika Balaji Warner, Julie Brahmer, et al.
Annals of the Rheumatic Diseases|April 5, 2023
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritisAnne R Bass, Noha Abdel-Wahab, Pankti D Reid, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse eventsJulie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, et al.
Seminars in Arthritis and Rheumatism|November 13, 2022
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working groupNilasha Ghosh, Nina Couette, Wouter H van Binsbergen, et al.
Journal of Endocrinological Investigation|September 26, 2023
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classificationsE Gatta, V Maltese, E Cimino, et al.
Seminars in Arthritis and Rheumatism|September 15, 2020
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping reviewAdam Kilian, Yu Pei Chock, Irvin J Huang, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Journal of Endocrinological Investigation|June 10, 2024
Changes in body composition in early breast cancer patients treated with aromatase inhibitorsR Pedersini, G Schivardi, L Laini, et al.
The Journal of Investigative Dermatology|May 23, 2022
Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance StudyThomas K Le, Isabelle Brown, Rebecca Goldberg, et al.
Journal of Translational Medicine|March 5, 2024
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockadeShuming Chen, Tracee L McMiller, Abha Soni, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse EventsJarushka Naidoo, Jiajia Zhang, Evan J Lipson, et al.
The Oncologist|July 27, 2024
Immune-related encephalitis after immune checkpoint inhibitor therapyMonica W Buckley, Aanika Balaji Warner, Julie Brahmer, et al.
Annals of the Rheumatic Diseases|April 5, 2023
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritisAnne R Bass, Noha Abdel-Wahab, Pankti D Reid, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse eventsJulie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, et al.
Seminars in Arthritis and Rheumatism|November 13, 2022
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working groupNilasha Ghosh, Nina Couette, Wouter H van Binsbergen, et al.
Journal of Endocrinological Investigation|September 26, 2023
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classificationsE Gatta, V Maltese, E Cimino, et al.
Seminars in Arthritis and Rheumatism|September 15, 2020
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping reviewAdam Kilian, Yu Pei Chock, Irvin J Huang, et al.
Pageof 17